FDA wants more CMC data for taliglucerase alfa

Protalix Biotherapeutics Inc. (NYSE-A:PLX) said FDA requested additional data regarding the CMC section of an NDA for taliglucerase alfa to treat Gaucher's disease. Protalix, which plans to submit the...